Analysts on Wall Street project that ResMed (RMD) will announce quarterly earnings of $2.49 per share in its forthcoming report, representing an increase of 13.2$1.32 billion, increasing 8.1% from the same quarter last year.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts ove ...